Securities

Securities Law360 provides breaking news and analysis on securities law and corporate governance. Coverage includes high-stakes shareholder litigation, government enforcement actions, and related policy developments.



Sign up for a 7-day FREE trial today!



Latest News in Securities

  • July 08, 2026

    Baxter Beats Stable Value Fund 401(k) Plan Suit, For Good

    Baxter International permanently defeated a proposed class action claiming the relatively low returns of the medical products company's employee retirement plan were evidence of mismanagement, after an Illinois federal judge ruled Tuesday the allegations only show the stable value fund in the plan "may not have been best in class — nothing more."

  • July 08, 2026

    Meta Nears Ax Of Suits Over Pump-And-Dump Facebook Ads

    A California federal judge said Wednesday he's inclined to toss two proposed class actions alleging that Meta's AI tools enabled investment schemes advertised on Facebook, saying the litigation appears to be "on all fours" with a recent ruling in the same district finding such state claims are barred under federal securities law.

  • July 08, 2026

    Citi Should Be Shrinking, Not Shopping, Sen. Warren Says

    If Citigroup thinks now is a good time to expand its "financial empire" with a major acquisition, its already-mammoth size and past compliance troubles should make it think again, the top Democrat on the U.S. Senate Banking Committee told the bank on Wednesday.

  • July 08, 2026

    SEC's $1.5M Musk Deal OK'd Despite Court's 'Misgivings'

    Despite having "significant misgivings" about the U.S. Securities and Exchange Commission's $1.5 million settlement over Elon Musk's initial purchase of Twitter stock in 2022, a D.C. federal judge signed off on the parties' resolution Wednesday.

  • July 08, 2026

    AstraZeneca Employee Traded On Icosavax Deal, SEC Says

    The U.S. Securities and Exchange Commission on Wednesday accused a former AstraZeneca Pharmaceuticals LP employee of using nonpublic information to trade ahead of the company's $1.1 billion acquisition of vaccine design company Icosavax Inc., yielding approximately $10,000 in illicit gains.

See more Securities news

Securities

Areas of Coverage

  • AGENCIES
  • U.S. Securities and Exchange Commission
  • U.S. Commodity Futures Trading Commission
  • U.S. Department of Justice
  • Self-regulatory organizations
  • State and international securities regulators
  • POLICY & REGULATION
  • Dodd-Frank Act
  • Employee Retirement Income Security Act
  • Investment Advisers Act
  • Investment Company Act
  • Private Securities Litigation Reform Act
  • Foreign Corrupt Practices Act
  • Sarbanes-Oxley Act
  • Securities Act
  • Securities Exchange Act
  • Securities Investor Protection Act
  • International banking legislation and regulation
  • ENFORCEMENT
  • Fraud investigations
  • Insider trading charges
  • LITIGATION
  • Accounting and securities fraud suits
  • Shareholder class actions, including derivative suits
  • Suits over mortgage-backed securities, credit-default swaps, and other high-risk assets
  • Proxy battles and hostile takeover suits
  • Securities disputes in bankruptcy cases
  • ERISA suits
  • PROFILES
  • Personnel moves
  • Profiles of securities practices

Readership

  • Securities and white collar lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals